U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07835789) titled 'Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer' on Sept. 17.

Brief Summary: This phase II trial compares repeat radiation therapy (RT) to standard drug treatment alone in treating patients with stage II-III non-small cell lung cancer (NSCLC) that has come back after initial radiation at or adjacent to the site of the original tumor (locally recurrent). Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Chemotherapy drugs used in standard drug treatment work in different ways to stop the growth of tumor cells, either by killing the cells, by s...